Display options
Cite
Siesky B, Harris A, Verticchio Vercellin AC, et al. COVID-19 Pandemic: Are We Back to Normal?. J Glaucoma. 2021;30(1):e24-e25doi: 10.1097/IJG.0000000000001699.
Siesky, B., Harris, A., Verticchio Vercellin, A. C., Kalafatis, N., & Tsai, J. C. (2021). COVID-19 Pandemic: Are We Back to Normal?. Journal of glaucoma, 30(1), e24-e25. https://doi.org/10.1097/IJG.0000000000001699
Siesky, Brent, et al. "COVID-19 Pandemic: Are We Back to Normal?." Journal of glaucoma vol. 30,1 (2021): e24-e25. doi: https://doi.org/10.1097/IJG.0000000000001699
Siesky B, Harris A, Verticchio Vercellin AC, Kalafatis N, Tsai JC. COVID-19 Pandemic: Are We Back to Normal?. J Glaucoma. 2021 Jan 01;30(1):e24-e25. doi: 10.1097/IJG.0000000000001699. PMID: 33351551.
Copy Download .nbib Format: NLM
Share it on

J Glaucoma. 2021 Jan 01;30(1):e24-e25. doi: 10.1097/IJG.0000000000001699.

COVID-19 Pandemic: Are We Back to Normal?.

Journal of glaucoma

Brent Siesky, Alon Harris, Alice C Verticchio Vercellin, Nicholas Kalafatis, James C Tsai

Affiliations

  1. Department of Ophthalmology, Icahn School of Medicine at Mount Sinai Hospital.
  2. IRCCS-Fondazione Bietti, Rome.
  3. Department of Ophthalmology, University of Pavia, Pavia, Italy.
  4. Indiana University School of Medicine Indianapolis, IN.
  5. New York Eye and Ear Infirmary of Mount Sinai/Icahn School of Medicine at Mount Sinai.

PMID: 33351551 DOI: 10.1097/IJG.0000000000001699

[No abstract available.]

Conflict of interest statement

Disclosure: A.H. would like to disclose that he received remuneration from Adom, Qlaris, and Luseed for serving as a consultant, and he serves on the board of Adom and Phileas Pharma. A.H. also holds

References

  1. Yancy CW. COVID-19 and African Americans. JAMA. 2020;323:1891–1892. - PubMed
  2. Mahajan UV, Larkins-Pettigrew M. Racial demographics and COVID-19 confirmed cases and deaths: a correlational analysis of 2886 US counties. J Public Health (Oxf). 2020;42:445–447. - PubMed
  3. Congdon N, O’Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–485. - PubMed
  4. Friedman DS, Wolfs RC, O’Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532–538. - PubMed
  5. Harris A, Guidoboni G, Siesky B, et al. Ocular blood flow as a clinical observation: Value, limitations and data analysis. Prog Retin Eye Res. 2020:100841. - PubMed
  6. Ferdinand KC. Cardiovascular disease in blacks: can we stop the clock? J Clin Hypertens (Greenwich). 2008;10:382–389. - PubMed
  7. Siesky B, Harris A, Racette L, et al. Differences in ocular blood flow in glaucoma between patients of African and European descent. J Glaucoma. 2015;24:117–121. - PubMed
  8. Siesky B, Harris A, Carr J, et al. Reductions in retrobulbar and retinal capillary blood flow strongly correlate with changes in optic nerve head and retinal morphology over 4 years in open-angle glaucoma patients of African descent compared with patients of European descent. J Glaucoma. 2016;25:750–757. - PubMed
  9. Siesky BA, Harris A, Racette L, et al. Retinal oximetry in primary open-angle glaucoma: differences in patients of african and european descent. Invest Ophthalmol Vis Sci. 2013;54:4471. - PubMed
  10. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120–128. - PubMed
  11. Leisman DE, Deutschman CS, Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Med. 2020;46:1105–1108. - PubMed
  12. Kang Y, Chen T, Mui D, et al. Cardiovascular manifestations and treatment considerations in covid-19. Heart. 2020;106:1132–1141. - PubMed

Publication Types